Respiratory syncytial virus (RSV) is a major cause of pediatric respiratory disease in Saudi Arabia, particularly among infants during the first six months of life. Saudi studies report RSV detection in approximately 20-26% of hospitalized children with respiratory illness, although estimates vary by population, settin...
Ammar A. Basabrain, Alaa M. Alkinani, Nedaa A. Alabdali et al.· Journal of Infection and Pub...· 0 citations
Camelid variable heavy-chain (VHH) nanobodies have emerged as a promising class of single-domain antibodies with significant potential for combating bacterial and parasitic infections. Their small molecular size, high solubility, exceptional physicochemical stability, and ability to recognize cryptic or conformational...
H. Gattan, T. Alandijany· Frontiers in Immunology· 0 citations
Abstract Hepatitis E virus (HEV) causes over 19 million infections annually, yet the molecular determinants governing its diverse clinical phenotypes and cross-genotype immunity remain incompletely synthesized. The ORF2 capsid protein is the sole structural component of the virion, the primary neutralizing antibody tar...
Shreif A. El-Kafrawy, S. S. Putra, A. Abbas et al.· Journal of General Virology· 0 citations
The available evidence indicates that camelid VHH represent a highly versatile and adaptable platform for antiviral therapeutics and diagnostics, with considerable potential to support pandemic preparedness and the development of broad-spectrum interventions against current and emerging viral diseases.
M. Mufrrih, T. Alandijany· Pharmaceuticals· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.